HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Lozano Selected Research

Coinfection

1/2021Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Lozano Research Topics

Disease

7Neoplasms (Cancer)
01/2023 - 08/2017
5Osteoporosis
03/2024 - 07/2012
5Infections
01/2023 - 01/2020
3Burns
07/2014 - 03/2006
3Metabolic Bone Diseases (Osteopenia)
07/2012 - 05/2009
3Wounds and Injuries (Trauma)
10/2011 - 08/2004
2Leishmaniasis
01/2023 - 01/2021
2Chagas Disease (American Trypanosomiasis)
12/2021 - 01/2021
2Osteosarcoma (Osteogenic Sarcoma)
04/2020 - 01/2018
2Bone Diseases (Bone Disease)
01/2019 - 04/2010
1Musculoskeletal Diseases (Musculoskeletal Disease)
03/2024
1Arthritis (Polyarthritis)
03/2024
1Persistent Infection
01/2023
1COVID-19
01/2022
1Bacterial Infections (Bacterial Infection)
11/2021
1Disease Progression
01/2021
1Parasitemia
01/2021
1Coinfection
01/2021
1Bone Neoplasms (Bone Cancer)
01/2018
1Bone Fractures (Bone Fracture)
01/2015
1Inflammation (Inflammations)
04/2013
1Bone Resorption
04/2012
1Hypoxia (Hypoxemia)
01/2012
1Body Weight (Weight, Body)
05/2011
1Hyperglycemia
05/2011
1Hypercholesterolemia
05/2011
1Hypertriglyceridemia
05/2011

Drug/Important Bio-Agent (IBA)

7Silicon Dioxide (Silica)FDA LinkGeneric
02/2023 - 08/2017
3parathyroid hormone-related protein (107-111)IBA
03/2024 - 10/2011
3Parathyroid Hormone-Related ProteinIBA
03/2024 - 05/2009
2Peptides (Polypeptides)IBA
03/2024 - 04/2010
2Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2019
2Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2020 - 01/2018
1Parathyroid Hormone (Parathormone)IBA
03/2024
1pleiotrophin (HARP)IBA
02/2023
1Phosphotransferases (Kinase)IBA
01/2023
1Estrogen ReceptorsIBA
01/2023
1CurcuminIBA
01/2023
1Epidermal Growth Factor (EGF)IBA
01/2023
1ZincIBA
01/2023
1IonsIBA
01/2023
1COVID-19 VaccinesIBA
01/2022
1DNA VaccinesIBA
01/2022
1CytokinesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2019
1AcidsIBA
01/2018
1AcetalsIBA
01/2018
1carbopol 940 (sodium polyacrylate)IBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1Concanavalin AIBA
01/2018
1LigandsIBA
01/2018
1Polysaccharides (Glycans)IBA
01/2018
1Sialic AcidsIBA
01/2018
1LectinsIBA
01/2018
1Plant LectinsIBA
01/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
08/2017
1Differentiation AntigensIBA
04/2013
1CateninsIBA
04/2013
1MethylprednisoloneFDA LinkGeneric
07/2012
1parathyroid hormone-related protein (107-139)IBA
04/2012
1Oxygen (Dioxygen)IBA
01/2012
1Insulin (Novolin)FDA Link
05/2011
1Exenatide (Byetta)FDA Link
05/2011
1Glucagon-Like Peptide 1 (GLP 1)IBA
05/2011
1ThrombinFDA Link
05/2007
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
05/2007
1Explosive Agents (Explosives)IBA
03/2006

Therapy/Procedure

7Therapeutics
12/2021 - 04/2010
2Drug Therapy (Chemotherapy)
12/2021 - 01/2019
1Lasers (Laser)
01/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2015
1Continuity of Patient Care
07/2014
1Skin Transplantation (Skin Grafting)
03/2006
1Artificial Skin
08/2004